Pharming Group NV (NASDAQ:PHAR)

Delayed Data
As of Nov 30
 +0.55 / +4.47%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Pharming Group NV have a median target of 19.00, with a high estimate of 37.00 and a low estimate of 6.00. The median estimate represents a +46.29% increase from the last price of 12.99.

Chart unavailable

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Pharming Group NV. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -86.25%
Growthannually 89.90%


Growthquarterly -61.63%
Growthannually 4.97%
Key to the earnings and sales forecast charts.